Human keratinocyte immortality is genetically recessive to the normal phenotype of limited replicative lifespan and appears to require the dysfunction of p53 and the cyclin D-Cdk inhibitor p16. In order to test for the inactivation of other candidate replicative lifespan genes in the immortal cells of human tumors, we developed a series of mortal and immortal keratinocyte cultures derived from neoplastic lesions of the head and neck which were amenable to molecular genetic analysis by the loss of heterozygosity (LOH) technique. The results indicate that keratinocyte immortalization in head and neck squamous cell carcinoma (SCC-HN) development involves the inactivation of at least two further pathways to senescence and four in all. Chromosomes 1, 4 and 7 carry genes representing immortality complementation groups C, B and D respectively and immortal keratinocytes showed LOH at either 4q32-q34 between D4S1554 and D4S171 (group B) or 7q31 (group D) but never 1q25 (group C). These results tentatively suggest that the genes responsible for the immortality complementation groups encode proteins on the same pathway to senescence. In addition, all of the immortal keratinocyte lines possessed high levels of telomerase activity and a suppressor of telomerase activity has been mapped to the short arm of chromosome 3p. Five out of eight lines showed LOH at 3p21.2-p21.3, a region which may carry a gene capable of suppressing SCC-HN telomerase. However, alternative mechanisms of telomerase reactivation were also suggested by our results. None of the above genetic alterations were seen in seven senescent neoplastic keratinocyte cultures. Other loci harbouring antiproliferative genes implicated in replicative lifespan showed few or no alterations and any alterations seen were additional to those described above.
Introduction
Human cells from a number of lineages including keratinocytes are known to exhibit a limited proliferative capacity in vitro (Hay¯ick, 1965; Rheinwald and Green, 1975) but in contrast, many human tumors, including squamous cell carcinoma of the head and neck (SCC-HN), contain variant cells which proliferate essentially inde®nitely and are designated immortal (Rheinwald and Beckett, 1981; Easty et al., 1981) .
There is persuasive evidence from the induction of immortality in human ®broblasts that cellular immortality involves the abrogation of both the p53 and RB-1 tumor suppressor gene pathways (Shay et al., 1991; Hara et al., 1991) and decreased regulation of the cell cycle in both G 1 and G 2 (Kaufmann et al., 1995) . Although these events are necessary to induce immortality (Wright et al., 1989; Radna et al., 1989) they are still insucient and a further genetic alteration which activates telomerase (Counter et al., 1992 (Counter et al., , 1994 ) is usually essential. Several human chromosomes have been shown to harbour antiproliferative genes which have been mapped to 1q25 (Karlsson et al., 1996) , 1q42 (Karlsson et al., 1996) , 2 (Uejima et al., 1995) , 3p21 (Rimessi et al., 1994) , 4q32-q34 (Ning et al., 1991 ; O Pereira-Smith ± personal communication), 6q14-q21 (Sandhu et al., 1996) , 6q21-qter (Sandhu et al., 1994) , 7q31-32 (Ogata et al., 1993) , 11p15 (Koi et al., 1993) , 17 (Casey et al., 1993) , 18 (Sasaki et al., 1994) and Xp11-ter respectively. Genetic complementation groups for the immortal phenotype have been identi®ed (Pereira-Smith and Smith, 1988) and although the complementation group A locus is unknown, genes assigned to chromosomes 4 (Ning et al., 1991) , 1 (Hensler et al., 1994) and 7 (Ogata et al., 1993) are thought to represent complementation groups B, C and D respectively. The chromosome 1 gene has been mapped to either the p arm or to 1q13-q31 , making the antiproliferative gene at 1q25 (Karlsson et al., 1996) a likely candidate. However, other studies indicate that more than one chromosome can limit replicative lifespan in the same immortal cell line, suggesting multiple pathways to cellular senescence (Sasaki et al., 1994) and some of these may not be related to the previously identi®ed complementation groups.
Of the loci described above only those representing the complementation groups and carried by chromosomes 1, 4 (Dimri et al., 1995) and 7 (unpublished data) have formally been shown to reactivate speci®c markers of replicative senescence (Dimri et al., 1995) in the appropriate target cells and only chromosome 3p has so far been reported to harbour a gene capable of suppressing telomerase (Ohmura et al., 1995) . Thus a de®nite link between the other loci and immortalization is less certain. Furthermore, only two studies (Ogata et al., 1993; Sandhu et al., 1994) have provided any molecular genetic evidence that the recipient cells harboured alterations in the relevant chromosomal regions, making it dicult to distinguish between gene dosage and gene replacement eects in many of the published monochromosome transfer experiments.
In contrast to in vitro models, far less is known of the cellular immortalization process in human tumor cells and in particular, whether the regions of human chromosomes thought to carry replicative lifespan genes show molecular defects such as loss of heterozygosity (LOH) which would be suggestive of a recessive mutation at the locus (Cavenee et al., 1983; Vogelstein et al., 1989) . Squamous cell carcinoma is an excellent system in which to address this question, since normal and malignant keratinocytes can be cultured under essentially the same conditons (Rheinwald and Beckett, 1981; Edington et al., 1995) and animal models of this tumor are available (Balmain and Brown, 1988) . Our previous work has shown that immortal keratinocytes arise late during the progression of squamous cell carcinoma of the head and neck (SCC-HN, Edington et al., 1995) , that the immortal phenotype is recessive to the phenomenon of limited replicative lifespan and involves a high frequency of allele loss (Edington et al., 1995) . This suggests that the process involves one or more recessive inactivating mutations. Two candidates are the p53 and the CDKN2A/p16
ink4A genes which are both inactivated or deleted in immortal but not usually in replicatively senescent neoplastic keratinocytes (Burns et al., 1993 Edington et al., 1995; Loughran et al., 1994 Loughran et al., , 1996 and we have suggested that the loss of these two suppressor genes in concert is a necessary but insucient condition to sustain the immortal keratinocyte phenotype in human SCC-HN (Loughran et al., 1994 (Loughran et al., , 1996 .
The aim of the present study was to use the classical molecular genetic approach of LOH (Cavenee et al., 1983; Vogelstein et al., 1989) to investigate the possible inactivation of any of the other, as yet uncloned, replicative lifespan genes in the pathogenesis of immortal malignant keratinocytes.
Results
Several neoplastic keratinocyte cultures of ®nite or inde®nite proliferative life span were analysed for genetic alterations on chromosomes 1, 3, 4, 6, 7, 11, 17, 18 and X by the LOH technique. We are con®dent that the changes observed did not occur in vitro because we used a culture system where malignant keratinocytes remain phenotypically stable for more than 200 population doublings (Rheinwald and Beckett, 1981) and we always perform genetic analysis on the cultures when they have completed 30 ± 50 population doublings without any observed slowed proliferation or crisis (Loughran et al., 1994; Edington et al., 1995) . Furthermore, we tested lines BICR 3 and BICR 63 for LOH at several loci on chromosomes 1, 4, 6 and 7 at 30 population doublings and again at 130 population doublings and found them still to be heterozygous (data not shown), thus illustrating the genetic stability of the lines during this period. The allele losses were generally restricted to small regions of the candidate chromosomes and were often interstitial, suggesting that they were relevent to the observed phenotypes.
The results show that alterations at the complementation group loci are mutually exclusive ( However, LOH was also seen at other loci thought to harbour replicative lifespan genes not representing complementation groups. In particular, three regions of chromosome 3p showed frequent LOH and this is interesting given the recent evidence that a repressor of telomerase locates to this region (Ohmura et al., 1995) . None of the senescent neoplastic keratinocyte cultures showed LOH at any of the above loci.
The idiograms of the three complementation group chromosomes and chromosomes 3 are described in the sections below.
Chromosomes 1, 4 and 7 (Complementation Groups C, B and D)
LOH was very common at a locus in distal 4q which is thought to carry a gene capable of inducing replicative senescence in a variety of human tumor cells and to represent complementation group B for immortality (M Bertram and O Pereira-Smith ± personal communication, Table 1 ). An idiogram of chromosome 4 is shown in Figure 1a and it can be seen that while LOH is not generally common on this chromosome, LOH was detected in 6/11 lines distal to D4S1554 and proximal to D4S171 (see BICR 19 and BICR 22). The maximum LOH for the lines showing LOH on chromosome 4 occurred at D4S408/D4S1535 (4q32-q34) where 6/8 (75%) of informative cases showed loss. LOH was also found at D4S194 and D4S1549 (4q26) where 3/4 and 2/ 3 cases showed loss respectively, but there is currently no evidence for a senescence gene at this locus. Examples of allele loss and retention at D4S408 are shown in Figure 1b . We are continuing to re®ne our mapping of this region to assist in the identi®cation of the candidate replicative lifespan gene in this region.
Two regions of chromosome 1, 1q25 and 1q42, have been shown to harbour antiproliferative activity by monochromosome transfer and somatic cell genetics (Karlsson et al., 1996) and the 1q13-q31 region is thought to represent the complementation group C for human cellular immortality making the 1q25 region the best candidate for the complementation group C locus. No LOH was seen on any part of chromosome 1 ( Figure  2 ) except for one microsatellite at 1q21 in line BICR 63 and the 1q42-qter region in lines BICR 18 and BICR 31 both of which were derived from very advanced tumors. Examples of allele loss and retention at D1S245 are shown in Figure 2b . If the complementation group C locus turns out to be nearer to 1q21 than 1q25 then BICR 63 might eventually be assigned to complementation group C since this line is unlikely to be group B or D. However, the evidence presently favours 1q25 as the complementation group C locus (Karlsson et al., 1996; Vojta et al., 1996) .
Chromosome 7 carries a replicative senescence gene representing the complementation group D (Ogata et al., 1993) and an idiogram of LOH on chromosome 7 (Figure 3a) illustrates a speci®c region of LOH at 7q31-q32 in two non-senescent SCC-HN lines BICR 7 and BICR 68. Examples of these losses are shown in Figure  3b .
LOH at 4q32-q34 and 7q31 was mutually exclusive and no line showed LOH at more than one complementation group locus. These results tentatively suggest that the genes mutated in the complementation group described by Pereira-Smith and Smith (1988) may encode products on the same molecular pathway to senescence. However, as many other human chromosomes have now been shown to harbour antiproliferative activity we tested these for their involvement in the immortal SCC-HN keratinocyte phenotype and the results are described below.
Chromosome 3
An antiproliferative gene for ovarian carcinoma has been mapped to chromosome 3p21.1-p21.2 (Rimessi et al., 1994) and recently a suppressor of telomerase activity has been mapped to 3p (Ohmura et al., 1995) . Our own preliminary data from monochromosome transfer experiments suggests that there is a suppressor of immortal keratinocyte telomerase activity which maps to microsatellites D3S1478 and D3S1076 at 3p21.2-p21.3. (A Cuthbert, J Bond, EK Parkinson and RF Newbold ± unpublished data). Examination of the LOH (Figure 4 ) and telomerase data (Table 2) from all our cell cultures shows that ®ve out of eight informative telomerase-positive cultures showed LOH at D3S1478 and/or D3S1076. None of our senescent telomerase-negative cultures showed LOH at these loci (Table 2) . Furthermore, culture BICR 7 which appears to be an example of a cell line in crisis (Edington et al., 1995) , was telomerase-negative at early passage and retained heterozygosity at D3S1478 (Table 2, Figure  4a ). Even at later passage at high density BICR 7 replicated poorly and possessed less than 20% of the telomerase activity of the immortal lines. The region 3p13-cen also commonly showed LOH in the nonsenescent head and neck cultures with eight out of ten informative cases showing LOH, the exceptions being BICR 6 and BICR 68. The 3p25-pter region also showed LOH in three of four informative cases Genetic analysis of squamous cancer O Loughran et al studied at D3S1273 and in all three at D3S1038. In all four dierent regions of LOH at 3p13-cen, 3p14-p21.3, 3p22-p24 and 3p25-pter were identi®ed in the SCC-HN lines with no detectable LOH on 3q. One or more regions of chromosome 3p may well carry genes which repress telomerase but the total retention of heterozygosity at all informative 3p markers in the telomerase-positive line BICR 68 suggests that there is at least one alternative mechanism of telomerase reactivation to the loss of the 3p suppressor(s). Examples of allele loss and retention at D3S1067 are shown in Figure 4b .
LOH on the X chromosome and other candidate loci
The other chromosomal loci known to have antiproliferative activity in immortal human cells were tested for LOH in immortal SCC-HN. In addition to the two lines which showed LOH at 1q42-qter, described above, BICR 19 and BICR 31 showed LOH at 6q13-q16, BICR 78 showed LOH at 11p15.5 and BICR 18 and BICR 22 at 18q22-qter. However, there was no LOH at Xp11-pter which is known to carry an antiproliferative gene for hamster ®broblasts , although study of the X chromosome was hampered by the lack of informative cases, most especially in male lines. Similarly we could not detect LOH on chromosome 5q which harbours the mortalin gene (Kaul et al., 1995) or on chromosome 17q21 which harbours the prohibitin gene (White et al., 1991) . We also failed to detect any LOH on chromosome 21. These results illustrate that LOH is not generally common in our SCC-HN cell lines and emphasise the possible importance of the more frequent alterations on chromosomes 3 and 4 described above.
Furthermore, the LOH on chromosomes 1q42-qter, 6q13-q16, 11p15.5 and 18q22-qter were all additional to the losses described at the other loci and were always found in cell lines derived from advanced tumors.
Discussion
Our previous studies have indicated that the immortal phenotype of neoplastic head and neck keratinocytes is showing examples of the LOH described above associated with p53 dysfunction (Burns et al., 1993; Edington et al., 1995) , CDKN2A/p16 ink4A dysfunction (Loughran et al., 1994 (Loughran et al., , 1996 and a high frequency of allele loss at other genetic loci indicative of multiple suppressor gene loss (Edington et al., 1995, see also  Table 2 ). Therefore, since many other human chromosomal loci have been shown to have antiproliferative eects reminiscent of replicative senescence when transferred into immortal cells Karlsson et al., 1996; Uejima et al., 1995; Rimessi et al., 1994; Ning et al., 1991; Sandhu et al., 1994 Sandhu et al., , 1996 Ogata et al., 1993; Koi et al., 1993; Casey et al., 1993; Sasaki et al., 1994; Wang et al., 1992) we decided to investigate the role of these loci in neoplastic human keratinocyte immortalization. Furthermore, prior to our study there was no molecular genetic evidence to support the inactivation of any of the above replicative lifespan genes in the immortal cells of human tumors. In order to elucidate the mechanisms of cellular immortality and its role in human cancer we developed a series of mortal and immortal human keratinocyte lines from SCC-HN which were amenable to molecular genetic analysis by the LOH technique (Edington et al., 1995) .
The results show that the most commonly altered loci thought to harbour replicative lifespan genes in immortal SCC-HN keratinocytes were the regions 3p21.2-p21.3 (63%) and 4q32-q34 (the complementation group B locus, 63%). Furthermore, two of the lines not showing LOH at 4q32-q34 did show LOH at 7q31 (the complementation group D locus) and LOH at 4q32-q34 and 7q31 was mutually exclusive. There was no LOH at any of the genetic loci investigated in neoplastic keratinocytes which were senescent in vitro, consistent with the notion that the genes mapping to chromosomes 3, 4 and 7 may be involved in the control of keratinocyte replicative lifespan but with the reservation that the neoplastic keratinocytes which senesce show a very low frequency of allele loss overall (Edington et al., 1995) . It has been suggested that multiple genetic routes to senescence exist (Pereira-Smith and Smith, 1988; Sasaki et al., 1994) and dierent recessive mutations are predicted to exist within the same tumor type (Pereira-Smith and Smith, 1988) . These mutations may be mutually exclusive (Pereira-Smith and Smith, 1988) or additive (Sasaki et al., 1994) . Our results show that LOH at the complementation group B and D loci is mutually exclusive, suggesting that the genes responsible encode products on the same pathway to replicative senescence. Our data also suggest that several pathways to senescence exist (Sasaki et al., 1994) since the immortal SCC-HN phenotype appears to depend on the inactivation of multiple genes. Line BICR 7, is non-senescent, but has a low cloning eciency and resembles a cell population in crisis (Edington et al., 1995) . This line has lost both p53 (Burns et al., 1993) and CDKN2A/p16 ink4A (Loughran et al., 1996) function, in addition to showing LOH at 7q31 (the complementation group D locus). However, the phenotype of BICR 7 is most likely explained by recent results showing it to have very low levels of telomerase (Table 2 ) whereas all immortal SCC-HN keratinocytes tested had very high levels. Thus abrogation of at least four pathways involving p53, CDKN2A, the complementation group genes and the regulation of telomerase appear essential to maintain the immortal phenotype of SCC-HN keratinocytes. Others have also noted the consistent inactivation of the p53 and pRb pathways and the upregulation of telomerase in a range of immortal human tumor cell lines belonging to the dierent complementation groups and concluded that the genes responsible for the complementation groups must reside on a dierent pathway to senescence from the other three (Whitaker et al., 1995) . The idea that multiple pathways to senescence exist is not necessarily at variance with the observation that genetic complementation of the immortal phenotype can be achieved (Pereira-Smith and Smith, 1988) , since only one of the four pathways presently known may be inactivated by complementary mutations.
A gene mapping to chromosome 3p has been reported to inhibit telomerase, cause renewed telomeric attrition and result in delayed proliferation arrest (Ohmura et al., 1995) . Furthermore, antiproliferative genes thought to cause the senescence of ovarian cancer cells have been mapped to 3p21.1-p21.2 and 3p24 (Rimessi et al., 1994) . Our results showed several regions of LOH on 3p in our neoplastic head and neck cultures that evaded normal senescence, namely 3p13-cen, 3p14-p21.3, 3p22-p24 and 3p25-pter. All of these regions might be considered as candidates for the telomerase repressor since high levels of telomerase have been detected in all the immortal head and neck cell lines we have tested but not in the mortal cultures ( Table 2 ). The monochromosome transfer of an intact chromosome 3 into line BICR 31 appears to result in the repression of telomerase and deletion analysis of immortal, telomerase-positive, segregant colonies from these experiments is being carried out to map the position of the repressor. Preliminary data suggests that the telomerase suppressor maps close to microsatellites D3S1478 and D3S1076. However, the lack of LOH at these loci in lines BICR 18, BICR 22 and BICR 68 which have high levels of telomerase, suggests alterative mechanisms for the reactivation of the enzyme, other than the inactivation of a suppressor gene on 3p, as also concluded by Ohmura et al. (1995) in their study of renal cell carcinoma.
The functions of the antiproliferative genes at 1q42-qter, 6q13-q16, 11p15 and on chromosome 18 are not known and it is unclear whether these genes are really related to the process of replicative senescence. Our data shows that these loci were only altered in a few lines derived from advanced tumors and the alterations were additional to the ones previously described. It therefore still remains to be established whether these loci harbour true senescence genes. The genes encoding the proteins mortalin (Kaul et al., 1995) and prohibitin (White et al., 1991) have also been implicated in the process of replicative senescence but neither locus showed LOH in our immortal keratinocyte lines indicating that these genes are not common targets for inactivation in SCC-HN.
Another issue which has been the subject of much debate is the idea that limited replicative lifespan represents a barrier to tumor development or progression (Newbold, 1985) and that the molecules underpinning the process could be encoded by tumor suppressor genes (Sager, 1989) . With reference to this, it is notable that chromosomal imbalances suggestive of LOH have been noted in SCC-HN in vivo at 3p21-p24 (Maestro et al., 1993) , 4q (Nawroz et al., 1994) and 7q31 (Nawroz et al., 1994; Zenklusen et al., 1995) but the cloning of the relevant genes at these loci and the demonstration of loss of function mutations in vivo are necessary to consolidate this hypothesis. Nevertheless, these reports support our assertion that the genetic alterations we have observed are more likely to have occurred in vivo than in vitro.
In summary, our data provide further molecular genetic evidence that replicative lifespan genes may be altered in the immortal cells of a naturally occurring human malignancy, SCC-HN. Our results also support the hypothesis that there are at least four pathways involved in the limitation of replicative lifespan (Sasaki et al., 1994) but that the genes representing the dierent complementation groups (Pereira-Smith and Smith, 1988) may be on the same pathway. A further understanding of the candidate genes described in this article will be advanced greatly by their identi®cation and characterization but the keratinocyte should prove an excellent cell type in which to study their role in cellular immortalization and carcinogenesis.
Materials and methods

Cell cultures
All the neoplastic keratinocytes were cultured using 3T3 feeder layers as described elsewhere (Edington et al., 1996) . Immunoreactivity with keratin and involucrin con®rmed that the cultures were keratinocytes and reduced terminal maturation coupled with numerical chromosome aberrations con®rmed that even the senescent tumor-derived keratinocytes were neoplastic (Edington et al., 1995 (Edington et al., , 1996 . The source of normal DNA was lymphocytes and/or ®broblasts taken from the same patient as the keratinocytes, and DNA ®ngerprinting con®rmed that the cultures were unique and derived from the appropriate donors (Edington et al., 1996) . A list of the cell lines and cultures used in the study is given in Tables 1 and 2 .
De®nition of immortality, senecence and crisis
An immortal culture was classi®ed as one which proliferated through at least 130 population doublings. A senescent culture was de®ned as one which had a cloning eciency of less than 0.1%, did not double in number for 4 weeks, and was composed of large,¯at and terminally mature keratinocytes. The BICR 7 culture did not senesce normally but reproducibly ceased dividing after 40-45 population doublings. The BICR 7 colonies were composed of small vacuolated cells which eventually detached from the culture dish. This culture appeared to display the features of cells in crisis (Edington et al., 1995) .
Measurement of telomerase activity
Telomerase was measured by a modi®cation of the telomere repeat ampli®cation protocol (TRAP) technique (Kim et al., 1994) .
Neoplastic keratinocytes and six strains of normal epidermal keratinocytes were seeded at 10 5 cells per 5 cm dish together with lethally irradiated 3T3 feeder cells. When the cultures were around 50 ± 60% con¯uent the medium was changed and 16 ± 24 h later the feeders were removed with 0.02% EDTA and the dishes washed three times with phosphate-buered saline (PBS). The keratinocytes were then scraped into 1 ml of PBS centrifuged and snap frozen prior to storage at 7708C and extraction of the proteins for TRAP assay. As a control lethally irradiated 3T3 cells were seeded without keratinocytes (mock plates) and were treated in exactly the same way as the test cultures. The mock plates were always telomerase negative. Normal keratinocytes were also cultured using Clonectics Keratinocyte Growth Medium (Tissue Culture Services, UK). In most cases the normal keratinocytes were completely negative for telomerase at the protein concentrations used but in one strain, on one occasion, a faint ladder could be detected at the highest protein concentration.
Cell pellets were lysed for 30 min on ice in 200 ml of ice cold lysis buer (10 mM Tris-HCl, pH 7.5), 1 mM MgCl 2 , 1 mM EGTA, 0.5% CHAPS, 10% glycerol, 5 mM bmercaptoethanol, 0.1 mM PMSF, Piatyszek et al., 1995) . Centrifugation of the lysate at 14 000 g for 30 min at 48C pelleted the cell debris, allowing 160 ml of the supernatant to be removed, snap frozen and stored at 7808C. Protein concentrations were measured with a Coomassie protein assay kit. Telomerase activity was determined from 0.5 mg protein, using the one tube PCR-based protocol. Wax barrier tubes were prepared in advance and stored for up to 3 weeks at room temperature. 100 ng of the CX oligonucleotide in Tris-HCl pH 8.3) was dehydrated and sealed beneath a Perkin Elmer Ampliwax barrier (PCR cycles of 838C for 5 min to melt the wax gem and slow cooling to 258C at a rate of 18C 5 s). Telomerase mediated extension of the TS primer was achieved during a 30 min incubation at room temperature using a 50 ml reaction mixture containing reaction buer (20 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 68 mM KCl, 0.5% Tween 20, 1 mM EGTA), 100 ng TS primer, 0.5 mM T4 gene 32 protein, 50 ml each dinucleoside triphosphate, 2 U Taq polymerase, 2 mCi each of 10 mCi/ml [a 32 P]CTP and [a 32 P]TTP 3000 Ci/mM. A 150 bp myogenin cDNA internal standard (a gift from Lauren S Gollahan) was included at ®ve attograms per reaction . The wax barrier was melted at 908C for 2 min and the reaction subjected to 30 PCR cycles of 948C for 30 s, 508C for 30 s, 728C for 45 s, followed by one cycle of 948C for 30 s, 508C for 30 s and 728C for 1 min. An RNase control tube was included to determine speci®city. Reaction tubes were frozen for at least 1 h to removal of the wax plug. 25 ml of the PCR products were visualised on a 17613.5 cm 10% polyacrylamide non-denaturing gel, run in 0.56TBE buer for 45 min at 175 V and 105 min at 280 V until the xylene cyanol band is 5 cm from the bottom of the gel. Gels were ®xed in 50% ethanol, 0.5 M NaCl and 40 mM sodium acetate (pH 4.2) for 20 min and dried for 1 h prior to exposure to a phosphor screen for an hour. The intensity of the telomerase-derived ladders and internal standards were determined on a PhosphorImager using ImageQuant software. Quanti®cation was attained as log 10 of the sum of the peaks of each sample normalised to the signal from the internal standard.
DNA isolation, Southern blotting and RFLP analysis
The details of DNA isolation and analysis of the pMUC7 and AT III RFLPs by Southern blotting and by agarose gel electrophoresis of restriction enzyme digested PCR fragments respectively has been described previously (Loughran et al., 1994; Edington et al., 1995) .
Microsatellite analysis
All PCRs of microsatellite sequences were carried out in the same way. Total reaction volumes were 25 ml containing 40 ± 100 ng DNA, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 10% dimethylsulfoxide, 140 ± 350 ng of each primer, 200 mM concentrations of each deoxynucleotide triphosphate, and 1 ml of [a 32 P]dCTP, 0.1 mBq/ml. The mixture was heated to 948C, at which point 2.5 units of Taq polymerase (Perkin Elmer Cetus, Emeryville, CA) was added. Reactions were then subjected to six cycles for 948C for 30 s and 608C for 30 s, followed by 28 cycles of 948C, 30 s; 558C, 30 s; and 728C, 30 s. After this was completed, the reactions underwent further extension of 7 min at 728C and were cooled to 48C.
Thermocyclers were Perkin Elmer Cetus type 9600. In all cases cell line and normal DNA were ampli®ed simultaneously and each experiment was repeated at least once to ensure the validity of the results. The radiolabeled reaction products were separated on 4 ± 10.5% polyacrylamide gels under nondenaturing conditions. The gels were then exposed to X-ray ®lm to visualize the resolved reaction products. In some informative cases, two shadow bands were also visible in addition to the major bands. The shadow bands migrated at a slightly higher molecular weight than the major bands, and in the case of LOH both the major band and the shadow band representing the lost allele both disappeared. Thus, the presence of the shadow bands did not interfere with the interpretation of the result.
All primers were either obtained from Research Genetics, Inc. (Huntsville, AL) or synthesized on an Applied Biosystems 381 DNA Synthesizer or 392 DNA/RNA Synthesizer using the manufacturer's protocols and reagents from Cruachem (Glasgow, Scotland, UK). A list of the microsatellite markers used, but not illustrated in the Figures, is given in Table 3 . The chromosomal loci were obtained from the Human Genome Mapping Project.
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